{"id":86,"date":"2021-10-14T09:06:21","date_gmt":"2021-10-14T08:06:21","guid":{"rendered":"https:\/\/newmedicinesprosperitypartnership.ac.uk\/?page_id=86"},"modified":"2023-03-20T14:21:38","modified_gmt":"2023-03-20T14:21:38","slug":"people","status":"publish","type":"page","link":"https:\/\/newmedicinesprosperitypartnership.ac.uk\/?page_id=86","title":{"rendered":"People"},"content":{"rendered":"\n

Prosperity Partnership Core Group<\/h2>\n\n\n\n

The Core Group is set up to allow agile management of the Partnership, and to facilitate effective strategic and operational progress of the Partnership overall.<\/p>\n\n\n\n

\n
\n
\"\"
Professor Billy Kerr
PI and University of Strathclyde (UoS) Lead<\/figcaption><\/figure>\n<\/div><\/div>\n\n\n\n
\n
\"\"
Professor Peter Licence Univeristy of Nottingham (UoN) Lead<\/figcaption><\/figure>\n<\/div><\/div>\n\n\n\n
\n
\"\"
Dr Diane Coe
GSK Lead<\/figcaption><\/figure>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"
Dr David Lindsay
UoS Project Manager<\/figcaption><\/figure>\n<\/div><\/div>\n\n\n\n
\n
\"\"
Dr Nicholas Bennett
UoN Project Manager<\/figcaption><\/figure>\n<\/div><\/div>\n<\/div>\n\n\n\n

Research Theme Collaborators<\/h2>\n\n\n\n

For collaborators associated with our specific research themes, see:<\/p>\n\n\n\n

\n
AI-enabled Medicinal Chemistry<\/a><\/div>\n\n\n\n
Next Generation Synthesis & Catalysis<\/a><\/div>\n\n\n\n
Sustainable Processes <\/a><\/div>\n\n\n\n
Digital Manufacturing <\/a><\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

Strategic Advisory Board<\/h2>\n\n\n\n

The Strategic Advisory Board is responsible for monitoring the strategic direction of the programme, to ensure the highest standards of research are being met, and provides independent perspectives and advice at key decision points in the programme. The Board assesses major deliverables, technical risks, and strategic integration, and advises on future technical direction and appropriate routes for translation and impact arising from the research.<\/p>\n\n\n\n

    \n
  • Steve Elliot (Chair), CEO, Chemical Industries Association<\/li>\n\n\n\n
  • Peter Clark, Knowledge Transfer Manager, Innovate UK, KTN<\/li>\n\n\n\n
  • Pauline Lukey, Target to Treatment Consulting<\/li>\n\n\n\n
  • Rick Cousins, Cinnabar Consulting<\/li>\n\n\n\n
  • John Leonard, Cadence Pharma Consulting and ChemCinC<\/li>\n\n\n\n
  • Sophie Walton, Group Director for Academic Engagement, Centre for Process Innovation<\/li>\n\n\n\n
  • Chris Willis, Professor of Organic Chemistry, University of Bristol<\/li>\n\n\n\n
  • Robert Glen, Emeritus Professor of Chemistry, University of Cambridge<\/li>\n\n\n\n
  • Sue Gibson, Professor of Chemistry and Director of the Graduate School, Imperial College London (now retired)<\/li>\n\n\n\n
  • Samir Zard, Professor of Chemistry, Ecole Polytechnique, Paris, France<\/li>\n\n\n\n
  • Floris Rutjes, Professor of Synthetic Organic Chemistry and Vice-Dean of Education, Radboud University, Nijmegen, Netherlands<\/li>\n\n\n\n
  • Oliver Kappe, Professor of Chemistry, University of Graz, Austria, and Scientific Director of the Center for Continuous Flow Synthesis and Processing at the Research Center Pharmaceutical Engineering GmbH<\/li>\n\n\n\n
  • Talit Ghaffar, EPSRC Physical Sciences Portfolio Manager<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

    Prosperity Partnership Core Group The Core Group is set up to allow agile management of the Partnership, and to facilitate effective strategic and operational progress of the Partnership overall. Research …<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-layout-fullwidth.php","meta":{"footnotes":""},"class_list":["post-86","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/newmedicinesprosperitypartnership.ac.uk\/index.php?rest_route=\/wp\/v2\/pages\/86","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newmedicinesprosperitypartnership.ac.uk\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/newmedicinesprosperitypartnership.ac.uk\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/newmedicinesprosperitypartnership.ac.uk\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/newmedicinesprosperitypartnership.ac.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=86"}],"version-history":[{"count":24,"href":"https:\/\/newmedicinesprosperitypartnership.ac.uk\/index.php?rest_route=\/wp\/v2\/pages\/86\/revisions"}],"predecessor-version":[{"id":760,"href":"https:\/\/newmedicinesprosperitypartnership.ac.uk\/index.php?rest_route=\/wp\/v2\/pages\/86\/revisions\/760"}],"wp:attachment":[{"href":"https:\/\/newmedicinesprosperitypartnership.ac.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=86"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}